Human bone marrow-mesenchymal stem cells differentiation into brain-like endothelial cells

Area of Science:

• Stem cell biology
• Neuroscience
• Endothelial cell biology

Background:

• Brain microvascular endothelial cells (BMECs) form the blood-brain barrier (BBB), crucial for CNS homeostasis.
• Mesenchymal stem cells (MSCs), of mesodermal origin, are a potential source for BMEC differentiation.
• Current human induced pluripotent stem cell (hiPSC) to BMEC protocols require two steps: mesodermal and endothelial induction.

Purpose of the Study:

• To develop a streamlined protocol for differentiating MSCs directly into brain-like endothelial cells (BLECs).
• To circumvent the conventional mesodermal induction step for BMEC differentiation.
• To establish a robust in vitro BBB model using MSC-derived BLECs.

Main Methods:

• MSC differentiation induced by hypoxia, retinoic acid (RA), cobalt chloride (CoCl2), and sodium sulfite (Na2SO3).
• Optimization of differentiation media (IMDM, EGM-2, Endopan) and supplements (B27, FBS).
• Assessment of MSC viability (MTT assay) and BLEC functionality (tube formation assay).

Main Results:

• Immunocytochemistry confirmed expression of BMEC markers (ZO-1, CD31, occludin) in differentiated cells.
• The resulting cells exhibited phenotypic and functional characteristics of brain microvascular endothelium.
• The protocol successfully generated BLECs from MSCs without a mesodermal induction step.

Conclusions:

• A novel, streamlined MSC-based protocol efficiently differentiates cells into BLECs.
• This method bypasses the need for mesodermal induction, simplifying BMEC generation.
• The resulting in vitro BBB model is physiologically relevant for neurological disease research and drug screening.